X-16150395-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_ModerateBP6_ModerateBP7BS2
The NM_005314.3(GRPR):c.504C>T(p.Ser168Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000367 in 1,206,278 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 126 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00014 ( 0 hom., 5 hem., cov: 21)
Exomes 𝑓: 0.00039 ( 0 hom. 121 hem. )
Consequence
GRPR
NM_005314.3 synonymous
NM_005314.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.559
Genes affected
GRPR (HGNC:4609): (gastrin releasing peptide receptor) Gastrin-releasing peptide (GRP) regulates numerous functions of the gastrointestinal and central nervous systems, including release of gastrointestinal hormones, smooth muscle cell contraction, and epithelial cell proliferation and is a potent mitogen for neoplastic tissues. The effects of GRP are mediated through the gastrin-releasing peptide receptor. This receptor is a glycosylated, 7-transmembrane G-protein coupled receptor that activates the phospholipase C signaling pathway. The receptor is aberrantly expressed in numerous cancers such as those of the lung, colon, and prostate. An individual with autism and multiple exostoses was found to have a balanced translocation between chromosome 8 and a chromosome X breakpoint located within the gastrin-releasing peptide receptor gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.37).
BP6
Variant X-16150395-C-T is Benign according to our data. Variant chrX-16150395-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 753760.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=0.559 with no splicing effect.
BS2
High Hemizygotes in GnomAd4 at 5 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GRPR | NM_005314.3 | c.504C>T | p.Ser168Ser | synonymous_variant | 2/3 | ENST00000380289.3 | NP_005305.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GRPR | ENST00000380289.3 | c.504C>T | p.Ser168Ser | synonymous_variant | 2/3 | 1 | NM_005314.3 | ENSP00000369643.2 |
Frequencies
GnomAD3 genomes AF: 0.000144 AC: 16AN: 111371Hom.: 0 Cov.: 21 AF XY: 0.000149 AC XY: 5AN XY: 33549
GnomAD3 genomes
AF:
AC:
16
AN:
111371
Hom.:
Cov.:
21
AF XY:
AC XY:
5
AN XY:
33549
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000153 AC: 28AN: 182989Hom.: 0 AF XY: 0.000178 AC XY: 12AN XY: 67555
GnomAD3 exomes
AF:
AC:
28
AN:
182989
Hom.:
AF XY:
AC XY:
12
AN XY:
67555
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000390 AC: 427AN: 1094907Hom.: 0 Cov.: 31 AF XY: 0.000336 AC XY: 121AN XY: 360325
GnomAD4 exome
AF:
AC:
427
AN:
1094907
Hom.:
Cov.:
31
AF XY:
AC XY:
121
AN XY:
360325
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000144 AC: 16AN: 111371Hom.: 0 Cov.: 21 AF XY: 0.000149 AC XY: 5AN XY: 33549
GnomAD4 genome
AF:
AC:
16
AN:
111371
Hom.:
Cov.:
21
AF XY:
AC XY:
5
AN XY:
33549
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 29, 2018 | - - |
GRPR-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 07, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at